×
About 325 results

ALLMedicine™ Dysfibrinogenemia Center

Research & Reviews  161 results

Comparison of different activators of coagulation by turbidity analysis of hereditary d...
https://doi.org/10.1097/MBC.0000000000001000
Blood Coagulation & Fibrinolysis : an International Journ... Marchi R, Neerman-Arbez M et. al.

Jan 14th, 2021 - Turbidity analysis is widely used as a quantitative technique in hereditary dysfibrinogenemia. We aimed to compare several coagulation triggers in hereditary dysfibrinogenemia and control plasmas. We included 20 patients with hereditary dysfibrino...

Screening method for congenital dysfibrinogenemia using clot waveform analysis with the...
https://doi.org/10.1111/ijlh.13358
International Journal of Laboratory Hematology REFERENCES; Arai S, Kamijo T et. al.

Oct 8th, 2020 - Congenital fibrinogen disorders (CFDs) are classified as afibrinogenemia or hypofibrinogenemia (Hypo), dysfibrinogenemia (Dys), or hypodysfibrinogenemia (Hypodys), according to functional and antigenic fibrinogen concentrations. However, in routin...

Congenital fibrinogen disorder with a compound heterozygote possessing two novel FGB mu...
https://doi.org/10.1016/j.thromres.2020.08.031
Thrombosis Research; Yoda M, Kaido T et. al.

Sep 1st, 2020 - Congenital fibrinogen disorders result from genetic mutations in FGA, FGB, or FGG resulting in quantitative fibrinogen deficiencies (afibrinogenemia or hypofibrinogenemia) or qualitative fibrinogen deficiencies (dysfibrinogenemia). Hypodysfibrinog...

A rare heterozygous variant in FGB (Fibrinogen Merivale) causing hypofibrinogenemia in ...
https://doi.org/10.1097/MBC.0000000000000951
Blood Coagulation & Fibrinolysis : an International Journ... Fager Ferrari M, Leinoe E et. al.

Aug 27th, 2020 - : Fibrinogen is essential for normal hemostasis. Congenital fibrinogen disorders (afibrinogenemia, hypofibrinogenemia, dysfibrinogenemia and hypodysfibrinogenemia), caused by pathogenic variants in the genes FGA, FGB and FGG, have the potential of...

A novel heterozygous mutation (γIIe367Thr) causes congenital dysfibrinogenemia in a Chi...
https://doi.org/10.1097/MBC.0000000000000948
Blood Coagulation & Fibrinolysis : an International Journ... Luo S, Xu Q et. al.

Aug 24th, 2020 - : The aim of this study was to elucidate the molecular defects in a Chinese family with dysfibrinogenemia. The fibrinogen activity was measured by the one-stage clotting method. The fibrinogen antigen was measured with immunoturbidimetry. The fibr...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  163 results

Comparison of different activators of coagulation by turbidity analysis of hereditary d...
https://doi.org/10.1097/MBC.0000000000001000
Blood Coagulation & Fibrinolysis : an International Journ... Marchi R, Neerman-Arbez M et. al.

Jan 14th, 2021 - Turbidity analysis is widely used as a quantitative technique in hereditary dysfibrinogenemia. We aimed to compare several coagulation triggers in hereditary dysfibrinogenemia and control plasmas. We included 20 patients with hereditary dysfibrino...

Fibryga - fibrinogen (human) kit-Octapharma USA Inc
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=007a93f4-d84b-1fa9-51ed-32f6140bf423

Dec 21st, 2020 - FIBRYGA is a human fibrinogen concentrate indicated for the treatment of acute bleeding episodes in adults and children with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia. FIBRYGA is not indicated for dysfibrin...

Screening method for congenital dysfibrinogenemia using clot waveform analysis with the...
https://doi.org/10.1111/ijlh.13358
International Journal of Laboratory Hematology REFERENCES; Arai S, Kamijo T et. al.

Oct 8th, 2020 - Congenital fibrinogen disorders (CFDs) are classified as afibrinogenemia or hypofibrinogenemia (Hypo), dysfibrinogenemia (Dys), or hypodysfibrinogenemia (Hypodys), according to functional and antigenic fibrinogen concentrations. However, in routin...

Congenital fibrinogen disorder with a compound heterozygote possessing two novel FGB mu...
https://doi.org/10.1016/j.thromres.2020.08.031
Thrombosis Research; Yoda M, Kaido T et. al.

Sep 1st, 2020 - Congenital fibrinogen disorders result from genetic mutations in FGA, FGB, or FGG resulting in quantitative fibrinogen deficiencies (afibrinogenemia or hypofibrinogenemia) or qualitative fibrinogen deficiencies (dysfibrinogenemia). Hypodysfibrinog...

A rare heterozygous variant in FGB (Fibrinogen Merivale) causing hypofibrinogenemia in ...
https://doi.org/10.1097/MBC.0000000000000951
Blood Coagulation & Fibrinolysis : an International Journ... Fager Ferrari M, Leinoe E et. al.

Aug 27th, 2020 - : Fibrinogen is essential for normal hemostasis. Congenital fibrinogen disorders (afibrinogenemia, hypofibrinogenemia, dysfibrinogenemia and hypodysfibrinogenemia), caused by pathogenic variants in the genes FGA, FGB and FGG, have the potential of...

see more →